What's in Sun Pharmaceutical Industries's pipeline?

Sun Pharmaceutical Industries has 6 drugs in our index: 6 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Sun Pharmaceutical Industries's portfolio?

Top competitors by shared drug class: , ANI Pharmaceuticals, Astellas Pharma, Bristol-Myers Squibb, Pfizer Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/sun-pharma.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-13 · How we verify

Sun Pharmaceutical Industries — Portfolio Competitive Intelligence Brief

Sun Pharmaceutical Industries (SUNPHARMA.NS) pipeline: 6 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

SUNPHARMA.NS (NSE) 6 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Winlevi	CLASCOTERONE	marketed	Androgen Receptor Inhibitor [EPC]	Androgen receptor	Dermatology	2020-01-01
Dacogen	decitabine	marketed	Nucleoside Metabolic Inhibitor [EPC]	DNA (cytosine-5)-methyltransferase 1	Oncology	2006-01-01
Levulan	AMINOLEVULINIC ACID	marketed	Optical Imaging Agent		Metabolic	1999-01-01
Lac-Hydrin	AMMONIUM LACTATE	marketed	alpha-Hydroxy Acid [EPC]		Immunology	1985-01-01
Westcort	HYDROCORTISONE VALERATE	marketed	Corticosteroid	Glucocorticoid receptor	Immunology	1978-01-01
Halog	HALCINONIDE	marketed	Corticosteroid [EPC]	Glucocorticoid receptor	Oncology	1974-01-01

Therapeutic area mix

Immunology · 2
Oncology · 2
Dermatology · 1
Metabolic · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

· 4 shared drug classes
ANI Pharmaceuticals · 2 shared drug classes
Astellas Pharma · 2 shared drug classes
Bristol-Myers Squibb · 2 shared drug classes
Pfizer Inc. · 2 shared drug classes
Sanofi · 2 shared drug classes
Allergan · 1 shared drug class
Advanz · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Sun Pharmaceutical Industries:

Cite this brief

Drug Landscape (2026). Sun Pharmaceutical Industries — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/sun-pharma. Accessed 2026-05-13.